Pharmaceutical Advertising in the Journal

Pharmaceutical Advertising in the Journal

To the Editor: I found it ironic that Dr. Douglas Waud's impassioned Sounding Board article (July 30 issue),* which strongly opposed the acceptance by physicians of gifts from pharmaceutical companies, either direct or indirect (e.g., a subsidy for registration at a scientific meeting), appeare...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1992-12, Vol.327 (23), p.1688-1689
1. Verfasser: Glass, A R
Format: Artikel
Sprache:eng
Schlagworte:
Advertising as Topic - standards
Drug Industry
Ethics
Periodicals as Topic
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1689
container_issue 23
container_start_page 1688
container_title The New England journal of medicine
container_volume 327
creator Glass, A R
description To the Editor: I found it ironic that Dr. Douglas Waud's impassioned Sounding Board article (July 30 issue),* which strongly opposed the acceptance by physicians of gifts from pharmaceutical companies, either direct or indirect (e.g., a subsidy for registration at a scientific meeting), appeared in a medical journal that carries substantial advertising from pharmaceutical companies. To the extent that such advertising revenue subsidizes the subscription rates for its readers, would Dr. Waud consider the Journal as a conduit for another "bribe" from the pharmaceutical industry to the medical profession? Does the editor of the Journal consider pharmaceutical advertising a bribe . . .
doi_str_mv 10.1056/NEJM199212033272314
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73341492</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73285022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-e409a5408c3d1cc84fd5296f429f091009a69fbb22e3ee5dbbb0c09aad567b3f3</originalsourceid><addsrcrecordid>eNqNkN1LwzAUxYMoc07_AhH6JIhUk9ykbR7HmB9jfjzoc0jTxHU07Uzagf-9HR34IuJ9uXB_5xy4B6Fzgm8I5snt83zxRISghGIAmlIg7ACNCQeIGcPJIRpjTLOYpQKO0UkIa9wPYWKERoQBF4SM0dXrSnmntOnaUqsqmhZb49sylPVHVNZRuzLRoul8rapTdGRVFczZfk_Q-938bfYQL1_uH2fTZawhSdvYMCwUZzjTUBCtM2YLTkViGRUWC4J7mgib55QaMIYXeZ5j3R9VwZM0BwsTdDnkbnzz2ZnQSlcGbapK1abpgkwBWP8E_YeQZhzTnRAGofZNCN5YufGlU_5LEix3TcpfmuxdF_v4Lnem-PEM1fX8euDOBVmbtfsz7RuBnXkB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73285022</pqid></control><display><type>article</type><title>Pharmaceutical Advertising in the Journal</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Glass, A R</creator><creatorcontrib>Glass, A R</creatorcontrib><description>To the Editor: I found it ironic that Dr. Douglas Waud's impassioned Sounding Board article (July 30 issue),* which strongly opposed the acceptance by physicians of gifts from pharmaceutical companies, either direct or indirect (e.g., a subsidy for registration at a scientific meeting), appeared in a medical journal that carries substantial advertising from pharmaceutical companies. To the extent that such advertising revenue subsidizes the subscription rates for its readers, would Dr. Waud consider the Journal as a conduit for another "bribe" from the pharmaceutical industry to the medical profession? Does the editor of the Journal consider pharmaceutical advertising a bribe . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM199212033272314</identifier><identifier>PMID: 1435911</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Advertising as Topic - standards ; Drug Industry ; Ethics ; Periodicals as Topic ; United States</subject><ispartof>The New England journal of medicine, 1992-12, Vol.327 (23), p.1688-1689</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-e409a5408c3d1cc84fd5296f429f091009a69fbb22e3ee5dbbb0c09aad567b3f3</citedby><cites>FETCH-LOGICAL-c367t-e409a5408c3d1cc84fd5296f429f091009a69fbb22e3ee5dbbb0c09aad567b3f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM199212033272314$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJM199212033272314$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,780,784,2757,2758,26102,27923,27924,52381,54063,64386</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1435911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glass, A R</creatorcontrib><title>Pharmaceutical Advertising in the Journal</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor: I found it ironic that Dr. Douglas Waud's impassioned Sounding Board article (July 30 issue),* which strongly opposed the acceptance by physicians of gifts from pharmaceutical companies, either direct or indirect (e.g., a subsidy for registration at a scientific meeting), appeared in a medical journal that carries substantial advertising from pharmaceutical companies. To the extent that such advertising revenue subsidizes the subscription rates for its readers, would Dr. Waud consider the Journal as a conduit for another "bribe" from the pharmaceutical industry to the medical profession? Does the editor of the Journal consider pharmaceutical advertising a bribe . . .</description><subject>Advertising as Topic - standards</subject><subject>Drug Industry</subject><subject>Ethics</subject><subject>Periodicals as Topic</subject><subject>United States</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkN1LwzAUxYMoc07_AhH6JIhUk9ykbR7HmB9jfjzoc0jTxHU07Uzagf-9HR34IuJ9uXB_5xy4B6Fzgm8I5snt83zxRISghGIAmlIg7ACNCQeIGcPJIRpjTLOYpQKO0UkIa9wPYWKERoQBF4SM0dXrSnmntOnaUqsqmhZb49sylPVHVNZRuzLRoul8rapTdGRVFczZfk_Q-938bfYQL1_uH2fTZawhSdvYMCwUZzjTUBCtM2YLTkViGRUWC4J7mgib55QaMIYXeZ5j3R9VwZM0BwsTdDnkbnzz2ZnQSlcGbapK1abpgkwBWP8E_YeQZhzTnRAGofZNCN5YufGlU_5LEix3TcpfmuxdF_v4Lnem-PEM1fX8euDOBVmbtfsz7RuBnXkB</recordid><startdate>19921203</startdate><enddate>19921203</enddate><creator>Glass, A R</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19921203</creationdate><title>Pharmaceutical Advertising in the Journal</title><author>Glass, A R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-e409a5408c3d1cc84fd5296f429f091009a69fbb22e3ee5dbbb0c09aad567b3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Advertising as Topic - standards</topic><topic>Drug Industry</topic><topic>Ethics</topic><topic>Periodicals as Topic</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glass, A R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glass, A R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmaceutical Advertising in the Journal</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1992-12-03</date><risdate>1992</risdate><volume>327</volume><issue>23</issue><spage>1688</spage><epage>1689</epage><pages>1688-1689</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor: I found it ironic that Dr. Douglas Waud's impassioned Sounding Board article (July 30 issue),* which strongly opposed the acceptance by physicians of gifts from pharmaceutical companies, either direct or indirect (e.g., a subsidy for registration at a scientific meeting), appeared in a medical journal that carries substantial advertising from pharmaceutical companies. To the extent that such advertising revenue subsidizes the subscription rates for its readers, would Dr. Waud consider the Journal as a conduit for another "bribe" from the pharmaceutical industry to the medical profession? Does the editor of the Journal consider pharmaceutical advertising a bribe . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>1435911</pmid><doi>10.1056/NEJM199212033272314</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1992-12, Vol.327 (23), p.1688-1689
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_73341492
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; New England Journal of Medicine
subjects Advertising as Topic - standards
Drug Industry
Ethics
Periodicals as Topic
United States
title Pharmaceutical Advertising in the Journal
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A53%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmaceutical%20Advertising%20in%20the%20Journal&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Glass,%20A%20R&rft.date=1992-12-03&rft.volume=327&rft.issue=23&rft.spage=1688&rft.epage=1689&rft.pages=1688-1689&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM199212033272314&rft_dat=%3Cproquest_cross%3E73285022%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73285022&rft_id=info:pmid/1435911&rfr_iscdi=true